Chinese Journal of Dermatology ›› 2022, Vol. 55 ›› Issue (4): 299-303.doi: 10.35541/cjd.20210734
• Original Articles • Previous Articles Next Articles
Tian Jing, Liang Yuan, Shen Chunping, Zhao Mutong, Wang Yang, Wang Shan, Jiao Lei, Ma Lin
Received:
2021-10-09
Revised:
2022-02-10
Online:
2022-04-15
Published:
2022-04-01
Contact:
Ma Lin
E-mail:bch_maleen@aliyun.com
Supported by:
Tian Jing, Liang Yuan, Shen Chunping, Zhao Mutong, Wang Yang, Wang Shan, Jiao Lei, Ma Lin. Analysis of short-term efficacy and safety of the first subcutaneous injection of dupilumab in the treatment of moderate-to-severe childhood atopic dermatitis[J]. Chinese Journal of Dermatology, 2022, 55(4): 299-303.doi:10.35541/cjd.20210734
[1] | Gandhi NA, Bennett BL, Graham NM, et al. Targeting key proximal drivers of type 2 inflammation in disease[J]. Nat Rev Drug Discov, 2016,15(1):35⁃50. doi: 10.1038/nrd4624. |
[2] | Macdonald LE, Karow M, Stevens S, et al. Precise and in situ genetic humanization of 6 Mb of mouse immunoglobulin genes[J]. Proc Natl Acad Sci U S A, 2014,111(14):5147⁃5152. doi: 10.1073/pnas.1323896111. |
[3] | Murphy AJ, Macdonald LE, Stevens S, et al. Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice[J]. Proc Natl Acad Sci U S A, 2014,111(14):5153⁃5158. doi: 10.1073/pnas.1324022111. |
[4] | Simpson EL, Bieber T, Guttman⁃Yassky E, et al. Two phase 3 trials of dupilumab versus placebo in atopic dermatitis[J]. N Engl J Med, 2016,375(24):2335⁃2348. doi: 10.1056/NEJMoa1610020. |
[5] | Blauvelt A, de Bruin⁃Weller M, Gooderham M, et al. Long⁃term management of moderate⁃to⁃severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1⁃year, randomised, double⁃blinded, placebo⁃controlled, phase 3 trial[J]. Lancet, 2017,389(10086):2287⁃2303. doi: 10.1016/S0140⁃6736(17)31191⁃1. |
[6] | de Bruin⁃Weller M, Thaçi D, Smith CH, et al. Dupilumab with concomitant topical corticosteroid treatment in adults with atopic dermatitis with an inadequate response or intolerance to ciclosporin A or when this treatment is medically inadvisable: a placebo⁃controlled, randomized phase III clinical trial (LIBERTY AD CAFÉ)[J]. Br J Dermatol, 2018,178(5):1083⁃1101. doi: 10.1111/bjd.16156. |
[7] | Simpson EL, Paller AS, Siegfried EC, et al. Efficacy and safety of dupilumab in adolescents with uncontrolled moderate to severe atopic dermatitis: a phase 3 randomized clinical trial[J]. JAMA Dermatol, 2020, 156(1):44⁃56. doi: 10.1001/jamadermatol. 2019.3336. |
[8] | Cork MJ, Thaçi D, Eichenfield LF, et al. Dupilumab in adolescents with uncontrolled moderate⁃to⁃severe atopic dermatitis: results from a phase IIa open⁃label trial and subsequent phase III open⁃label extension[J]. Br J Dermatol, 2020,182(1):85⁃96. doi: 10.1111/bjd.18476. |
[9] | Paller AS, Bansal A, Simpson EL, et al. Clinically meaningful responses to dupilumab in adolescents with uncontrolled moderate⁃to⁃severe atopic dermatitis: post⁃hoc analyses from a randomized clinical trial[J]. Am J Clin Dermatol, 2020,21(1):119⁃131. doi: 10.1007/s40257⁃019⁃00478⁃y. |
[10] | Paller AS, Siegfried EC, Thaçi D, et al. Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: a randomized, double⁃blinded, placebo⁃controlled phase 3 trial[J]. J Am Acad Dermatol, 2020,83(5):1282⁃1293. doi: 10.1016/j.jaad.2020.06. 054. |
[11] | Paller AS, Siegfried EC, Simpson EL, et al. A phase 2, open⁃label study of single⁃dose dupilumab in children aged 6 months to <6 years with severe uncontrolled atopic dermatitis: pharmacokinetics, safety and efficacy[J]. J Eur Acad Dermatol Venereol, 2021,35(2):464⁃475. doi: 10.1111/jdv.16928. |
[12] | Igelman S, Kurta AO, Sheikh U, et al. Off⁃label use of dupilumab for pediatric patients with atopic dermatitis: a multicenter retrospective review[J]. J Am Acad Dermatol, 2020, 82(2):407⁃411. doi: 10.1016/j.jaad.2019.10.010. |
[1] | Liu Bo, Song Xiaoting, Li Ruoyu, Zhao Zuotao. Clinical efficacy and safety of dupilumab in the treatment of atopic dermatitis [J]. Chinese Journal of Dermatology, 2022, 55(4): 295-298. |
[2] | Wen Guangdong, Mao Dandan, Zhang Yuanyuan, Dou Yuanqing, Zhao Pei, Wu Chenyu, Zhang Jianzhong. A case of generalized lichen amyloidosis treated with dupilumab: the first case reported in China [J]. Chinese Journal of Dermatology, 2022, 0(2): 20210694-e20210694. |
[3] | Chu Kaiyu, Mao Rongjun, Wang Jianxuan, Zhong Minhua, Mo Huifang. Clinical and pathological features of acral pseudolymphomatous angiokeratoma of children: a case report [J]. Chinese Journal of Dermatology, 2021, 54(8): 709-711. |
[4] | Han Xiaofeng, Sun Juan, Xu Jiaosheng, Ma Lin. Clinical analysis of 14 children with cerebriform sebaceous nevus [J]. Chinese Journal of Dermatology, 2021, 54(6): 529-531. |
[5] | Song Zhiqiang, Wang Huan. Advances in the treatment of atopic dermatitis: new medications, new methods and new models [J]. Chinese Journal of Dermatology, 2021, 54(2): 161-164. |
[6] | Wu Yuanyuan, Zheng Jie, Xiao Fengli. Analysis of factors influencing disease severity in 2 620 children with atopic dermatitis [J]. Chinese Journal of Dermatology, 2019, 52(12): 915-919. |
[7] | . Application of atopy patch test in diagnosing egg and milk allergy among children with atopic dermatitis [J]. Chinese Journal of Dermatology, 2010, 43(6): 378-381. |
[8] | . Clinical analysis of 53 cases of pediatric systemic lupus erythematosus [J]. Chinese Journal of Dermatology, 2008, 41(9): 576-578. |
[9] | WAN Chuan, WANG Lin, ZHANG Wen-yan, TANG Yuan, XU Chen, LI Wei, LI Gan-di, LIU Wei-ping. A study of subcutaneous panniculitis-like T-cell lymphoma in children [J]. Chinese Journal of Dermatology, 2007, 40(10): 594-597. |
[10] | LIU Ling-ling, DOU Xia, XIE Zhi-qimg, WANG Di, ZHENG Zhi-zhong, WEI Ming-hui, YU Bi-e, WANG Bao-xi, MA Dong-lai, LIN Lin, GONG Juan-qin, ZENG Fan-qin, GUO Qing, ZHU Xue-jun. Efficacy and Safety of TacroUmus Ointment for the Treatment of Atopic Dermatitis in Chinese Children [J]. Chinese Journal of Dermatology, 2005, 38(10): 608-611. |
[11] | Li Huizhu, Chen Kun. Comparative Study of Adult and Children Patients with Systemic Lupus Erythematosus [J]. Chinese Journal of Dermatology, 1996, 29(1): 9-11. |
[12] | LU Dang-Qing, CHEN Hong-Dun. Study of IgE-bearing Langerhans cells in lesions of atopic dermatitis and other dermatoses [J]. Chinese Journal of Dermatology, 1993, 26(4): 221-223. |
|